<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RAG Literature Analysis - EME2</title>
    <style>
        :root {
            --primary-color: #2c3e50;
            --secondary-color: #3498db;
            --success-color: #27ae60;
            --warning-color: #f39c12;
            --danger-color: #e74c3c;
            --light-bg: #f8f9fa;
            --border-color: #dee2e6;
        }
        
        * { margin: 0; padding: 0; box-sizing: border-box; }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
            line-height: 1.6;
            color: #333;
            background-color: #f5f7fa;
            padding: 20px;
        }
        
        .container { max-width: 1200px; margin: 0 auto; background: white; padding: 30px; border-radius: 10px; box-shadow: 0 2px 10px rgba(0,0,0,0.1); }
        
        header {
            text-align: center;
            margin-bottom: 30px;
            padding-bottom: 20px;
            border-bottom: 3px solid var(--secondary-color);
        }
        
        h1 { color: var(--primary-color); font-size: 2em; margin-bottom: 10px; }
        .subtitle { color: #666; font-size: 1.1em; }
        
        .prediction-card {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 25px;
            border-radius: 10px;
            margin-bottom: 30px;
            text-align: center;
        }
        
        .prediction-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin-top: 20px;
        }
        
        .prediction-item {
            background: rgba(255,255,255,0.2);
            padding: 15px;
            border-radius: 8px;
        }
        
        .prediction-value {
            font-size: 1.8em;
            font-weight: bold;
            margin-bottom: 5px;
        }
        
        .prediction-label { font-size: 0.9em; opacity: 0.9; }
        
        .severity-badge, .risk-badge {
            display: inline-block;
            padding: 8px 16px;
            border-radius: 20px;
            font-weight: bold;
            text-transform: uppercase;
            font-size: 0.9em;
        }
        
        .section {
            margin: 30px 0;
            padding: 20px;
            background: var(--light-bg);
            border-radius: 8px;
        }
        
        .section-title {
            color: var(--primary-color);
            border-bottom: 2px solid var(--secondary-color);
            padding-bottom: 10px;
            margin-bottom: 20px;
            font-size: 1.4em;
        }
        
        .publication {
            background: white;
            padding: 20px;
            margin-bottom: 15px;
            border-radius: 8px;
            border-left: 4px solid var(--secondary-color);
            box-shadow: 0 2px 4px rgba(0,0,0,0.05);
        }
        
        .pub-title {
            font-weight: bold;
            color: var(--primary-color);
            margin-bottom: 8px;
            font-size: 1.1em;
        }
        
        .pub-meta {
            color: #666;
            font-size: 0.9em;
            margin-bottom: 10px;
        }
        
        .pub-abstract {
            color: #333;
            line-height: 1.6;
            margin-top: 10px;
            padding-top: 10px;
            border-top: 1px solid #eee;
        }
        
        .pub-links {
            margin-top: 10px;
        }
        
        .pub-links a {
            display: inline-block;
            margin-right: 15px;
            color: var(--secondary-color);
            text-decoration: none;
            font-weight: 500;
        }
        
        .pub-links a:hover { text-decoration: underline; }
        
        .evidence-quality {
            display: inline-block;
            padding: 3px 8px;
            border-radius: 4px;
            font-size: 0.8em;
            font-weight: bold;
            text-transform: uppercase;
        }
        
        .evidence-high { background: #d4edda; color: #155724; }
        .evidence-medium { background: #fff3cd; color: #856404; }
        .evidence-low { background: #f8d7da; color: #721c24; }
        
        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(150px, 1fr));
            gap: 15px;
            margin: 20px 0;
        }
        
        .stat-box {
            background: white;
            padding: 15px;
            border-radius: 8px;
            text-align: center;
            box-shadow: 0 2px 4px rgba(0,0,0,0.05);
        }
        
        .stat-value {
            font-size: 1.5em;
            font-weight: bold;
            color: var(--secondary-color);
        }
        
        .stat-label {
            font-size: 0.85em;
            color: #666;
            margin-top: 5px;
        }
        
        .phenotypes-list {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            margin-top: 15px;
        }
        
        .phenotype-tag {
            background: var(--secondary-color);
            color: white;
            padding: 5px 12px;
            border-radius: 15px;
            font-size: 0.9em;
        }
        
        .confidence-bar {
            height: 20px;
            background: #e9ecef;
            border-radius: 10px;
            overflow: hidden;
            margin-top: 10px;
        }
        
        .confidence-fill {
            height: 100%;
            background: linear-gradient(90deg, #dc3545 0%, #ffc107 50%, #28a745 100%);
            border-radius: 10px;
            transition: width 0.3s ease;
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>ðŸ“š RAG Literature Analysis Report</h1>
            <div class="subtitle">
                Gene: <strong>EME2</strong> | 
                Organism TaxID: <strong>9606</strong>
            </div>
        </header>
        
        <div class="prediction-card">
            <h2>ðŸŽ¯ Phenotype Prediction Summary</h2>
            <div class="prediction-grid">
                <div class="prediction-item">
                    <div class="prediction-value">UNKNOWN</div>
                    <div class="prediction-label">Severity</div>
                </div>
                <div class="prediction-item">
                    <div class="prediction-value">UNKNOWN</div>
                    <div class="prediction-label">Risk Level</div>
                </div>
                <div class="prediction-item">
                    <div class="prediction-value">30%</div>
                    <div class="prediction-label">Confidence</div>
                </div>
            </div>
            <div class="confidence-bar">
                <div class="confidence-fill" style="width: 30.0%"></div>
            </div>
        </div>
        
        <div class="section">
            <h2 class="section-title">ðŸ“Š Literature Mining Statistics</h2>
            <div class="stats-grid">
                <div class="stat-box">
                    <div class="stat-value">10</div>
                    <div class="stat-label">Publications Retrieved</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">9</div>
                    <div class="stat-label">Open Access (PMC)</div>
                </div>
                <div class="stat-box">
                    <div class="stat-value">0</div>
                    <div class="stat-label">High-Quality Evidence</div>
                </div>
            </div>
        </div>

        <div class="section">
            <h2 class="section-title">ðŸ“š Retrieved Publications (10)</h2>

            <div class="publication">
                <div class="pub-title">A winged helix domain in human MUS81 binds DNA and modulates the endonuclease activity of MUS81 complexes.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Nucleic acids research | 
                    2013 | 
                    PMID: 23982516
                </div>
                <div class="pub-abstract">The MUS81-EME1 endonuclease maintains metazoan genomic integrity by cleaving branched DNA structures that arise during the resolution of recombination intermediates. In humans, MUS81 also forms a poorly characterized complex with EME2. Here, we identify and determine the structure of a winged helix (WH) domain from human MUS81, which binds DNA. WH domain mutations greatly reduce binding of the isolated domain to DNA and impact on incision activity of MUS81-EME1/EME2 complexes. Deletion of the WH domain reduces the endonuclease activity of both MUS81-EME1 and MUS81-EME2 complexes, and incisions made by MUS81-EME2 are made closer to the junction on substrates containing a downstream duplex, such as fork structures and nicked Holliday junctions. WH domain mutation or deletion in Schizosacchar...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/23982516/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834828/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Carcinogenesis | 
                    2010 | 
                    PMID: 20610542
                </div>
                <div class="pub-abstract">DNA strand breaks pose the greatest threat to genomic stability. Genetically determined mutagen sensitivity predisposes individuals to a variety of cancers, including glioma. However, polymorphisms in DNA strand break repair genes that may determine mutagen sensitivity are not well studied in cancer risk, especially in gliomas. We correlated genotype data for tag single-nucleotide polymorphisms (tSNPs) of DNA strand break repair genes with a gamma-radiation-induced mutagen sensitivity phenotype [expressed as mean breaks per cell (B/C)] in samples from 426 glioma patients. We also conducted analysis to assess joint and haplotype effects of single-nucleotide polymorphisms (SNPs) on mutagen sensitivity. We further validate our results in an independent external control group totaling 662 subj...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/20610542/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981459/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Phosphorylation by CK2 regulates MUS81/EME1 in mitosis and after replication stress.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Nucleic acids research | 
                    2018 | 
                    PMID: 29850896
                </div>
                <div class="pub-abstract">The MUS81 complex is crucial for preserving genome stability through the resolution of branched DNA intermediates in mitosis. However, untimely activation of the MUS81 complex in S-phase is dangerous. Little is known about the regulation of the human MUS81 complex and how deregulated activation affects chromosome integrity. Here, we show that the CK2 kinase phosphorylates MUS81 at Serine 87 in late-G2/mitosis, and upon mild replication stress. Phosphorylated MUS81 interacts with SLX4, and this association promotes the function of the MUS81 complex. In line with a role in mitosis, phosphorylation at Serine 87 is suppressed in S-phase and is mainly detected in the MUS81 molecules associated with EME1. Loss of CK2-dependent MUS81 phosphorylation contributes modestly to chromosome integrity, h...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29850896/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007509/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate Cancer.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Frontiers in oncology | 
                    2021 | 
                    PMID: 35087757
                </div>
                <div class="pub-abstract">This study aimed to identify critical cell cycle-related genes (CCRGs) in prostate cancer (PRAD) and to evaluate the clinical prognostic value of the gene panel selected. Gene set variation analysis (GSVA) of dysregulated genes between PRAD and normal tissues demonstrated that the cell cycle-related pathways played vital roles in PRAD. Patients were classified into four clusters, which were associated with recurrence-free survival (RFS). Moreover, 200 prognostic-related genes were selected using the Kaplan-Meier (KM) survival analysis and univariable Cox regression. The prognostic CCRG risk score was constructed using random forest survival and multivariate regression Cox methods, and their efficiency was validated in Memorial Sloan Kettering Cancer Center (MSKCC) and GSE70770. We identifi...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/35087757/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787043/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Frontiers in oncology | 
                    2020 | 
                    PMID: 32457837
                </div>
                <div class="pub-abstract">Splenic marginal zone lymphoma (SMZL) is a rare, indolent non-Hodgkin&#x27;s lymphoma that affects 0. 13 per 100,000 persons annually. Overall survival of SMZL is estimated to reach 8-11 years in most cases, but up to 30% of SMZL cases develop aggressive presentations resulting in greatly diminished time of survival. SMZL presents with a very heterogeneous molecular profile, making diagnosis problematic, and accurate prognosis even less likely. The study herein has identified a potential diagnostic gene expression signature with highly specific predictive utility, coined the SMZL-specific Gene Expression Signature (SSGES). Additionally, five of the most impactful markers identified within the SSGES were selected for a five-protein panel, for further evaluation among control and SMZL patient sam...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/32457837/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225304/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Frontiers in oncology | 
                    2023 | 
                    PMID: 36816926
                </div>
                <div class="pub-abstract">Colorectal cancer (CRC) is the third most prevalent malignancy and the one of most lethal cancer. Metastatic CRC (mCRC) is the third most common cause of cancer deaths worldwide. DNA damage response (DDR) genes are closely associated with the tumorigenesis and development of CRC. In this study, we aimed to construct a DDR-related gene signature for predicting the prognosis of mCRC patients. The gene expression and corresponding clinical information data of CRC/mCRC patients were obtained from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. A prognostic model was obtained and termed DDRScore by the multivariate Cox proportional hazards regression in the patients with mCRC. The Kaplan-Meier (K-M) and Receiver Operating Characteristic (ROC) curves were employed to ...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/36816926/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931195/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Structure-Specific Endonucleases and the Resolution of Chromosome Underreplication.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Genes | 
                    2019 | 
                    PMID: 30893921
                </div>
                <div class="pub-abstract">Complete genome duplication in every cell cycle is fundamental for genome stability and cell survival. However, chromosome replication is frequently challenged by obstacles that impede DNA replication fork (RF) progression, which subsequently causes replication stress (RS). Cells have evolved pathways of RF protection and restart that mitigate the consequences of RS and promote the completion of DNA synthesis prior to mitotic chromosome segregation. If there is entry into mitosis with underreplicated chromosomes, this results in sister-chromatid entanglements, chromosome breakage and rearrangements and aneuploidy in daughter cells. Here, we focus on the resolution of persistent replication intermediates by the structure-specific endonucleases (SSEs) MUS81, SLX1-SLX4 and GEN1. Their actions...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/30893921/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470701/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">PolÎ·, a Y-family translesion synthesis polymerase, promotes cellular tolerance of Myc-induced replication stress.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Journal of cell science | 
                    2018 | 
                    PMID: 29777036
                </div>
                <div class="pub-abstract">Growth of precancerous and cancer cells relies on their tolerance of oncogene-induced replication stress (RS). Translesion synthesis (TLS) plays an essential role in the cellular tolerance of various types of RS and bypasses replication barriers by employing specialized polymerases. However, limited information is available about the role of TLS polymerases in oncogene-induced RS. Here, we report that PolÎ·, a Y-family TLS polymerase, promotes cellular tolerance of Myc-induced RS. PolÎ· was recruited to Myc-induced RS sites, and PolÎ· depletion enhanced the Myc-induced slowing and stalling of replication forks and the subsequent generation of double-strand breaks (DSBs). Overexpression of a catalytically dead PolÎ· also promoted Myc-induced DSB formation. In the absence of PolÎ·, Myc-induced DS...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/29777036/" target="_blank">View on PubMed</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Novel molecular typing reveals the risk of recurrence in patients with early-stage papillary thyroid cancer.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    Thyroid research | 
                    2024 | 
                    PMID: 38556856
                </div>
                <div class="pub-abstract">Papillary thyroid cancer (PTC) is an indolent disease with a favorable prognosis but characterized by a high recurrence rate. We aimed to improve precise stratification of recurrence risk in PTC patients with early stage using multi-gene signatures. The present study was performed using data from The Cancer Genome Atlas (TCGA) and multi-center datasets. Unsupervised consensus clustering was used to obtain the optimal molecular subtypes and least absolute shrinkage and selection operator (LASSO) analysis was performed to identify potential genes for the construction of recurrence signature. Kaplan-Meier survival analysis and the log-rank test was used to detect survival differences. Harrells concordance index (C-index) was used to assess the performance of the DNA damage repair (DDR) recurr...</div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/38556856/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983671/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

            <div class="publication">
                <div class="pub-title">Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis.</div>
                <div class="pub-meta">
                    <span class="evidence-quality evidence-unknown">UNKNOWN</span> | 
                    International journal of molecular sciences | 
                    2021 | 
                    PMID: 34769200
                </div>
                <div class="pub-abstract">In the recent decade, the importance of DNA damage repair (DDR) and its clinical application have been firmly recognized in prostate cancer (PC). For example, olaparib was just approved in May 2020 to treat metastatic castration-resistant PC with homologous recombination repair-mutated genes; however, not all patients can benefit from olaparib, and the treatment response depends on patient-specific mutations. This highlights the need to understand the detailed DDR biology further and develop DDR-based biomarkers. In this study, we establish a four-gene panel of which the expression is significantly associated with overall survival (OS) and progression-free survival (PFS) in PC patients from the TCGA-PRAD database. This panel includes </div>
                <div class="pub-links">
                    <a href="https://pubmed.ncbi.nlm.nih.gov/34769200/" target="_blank">View on PubMed</a>
                    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584064/" target="_blank">View Full Text (PMC)</a>

                </div>
            </div>

        </div>
        
        <footer style="text-align: center; margin-top: 40px; padding-top: 20px; border-top: 1px solid #ddd; color: #666;">
            <p>Generated by K-Sites RAG System | Literature Mining with Semantic Analysis</p>
            <p>Using PubMed, PMC Open Access, and SentenceTransformer Embeddings</p>
        </footer>
    </div>
</body>
</html>
